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Abstract
Background: Data from epidemiological and animal model studies suggest that nutrition during pregnancy may
affect the health status of subsequent generations. These transgenerational effects are now being explained by
disruptions at the level of the epigenetic machinery. Besides in vitro environmental exposures, the possible impact
on the reprogramming of methylation profiles at imprinted genes at a much earlier time point, such as during
spermatogenesis or oogenesis, has not previously been considered. In this study, our aim was to determine
associations between preconceptional obesity and DNA methylation profiles in the offspring, particularly at the
differentially methylated regions (DMRs) of the imprinted Insulin-like Growth Factor 2 (IGF2) gene.
Methods: We examined DNA from umbilical cord blood leukocytes from 79 newborns, born between July 2005
and November 2006 at Duke University Hospital, Durham, NC. Their mothers participated in the Newborn
Epigenetics Study (NEST) during pregnancy. Parental characteristics were obtained via standardized questionnaires
and medical records. DNA methylation patterns at two DMRs were analyzed by bisulfite pyrosequencing; one DMR
upstream of IGF2 (IGF2 DMR), and one DMR upstream of the neighboring H19 gene (H19 DMR). Multiple regression
models were used to determine potential associations between the offspring’s DNA methylation patterns and
parental obesity before conception. Obesity was defined as body mass index (BMI) ≥30 kg/m2.
Results: Hypomethylation at the IGF2 DMR was associated with paternal obesity. Even after adjusting for several
maternal and newborn characteristics, we observed a persistent inverse association between DNA methylation in
the offspring and paternal obesity (b-coefficient was -5.28, P = 0.003). At the H19 DMR, no significant associations
were detected between methylation patterns and paternal obesity. Our data suggest an increase in DNA
methylation at the IGF2 and H19 DMRs among newborns from obese mothers, but a larger study is warranted to
further explore the potential effects of maternal obesity or lifestyle on the offspring’s epigenome.
Conclusions: While our small sample size is limited, our data indicate a preconceptional impact of paternal obesity
on the reprogramming of imprint marks during spermatogenesis. Given the biological importance of imprinting
fidelity, our study provides evidence for transgenerational effects of paternal obesity that may influence the
offspring’s future health status.
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Background
Environmental exposures acquired early in life have been
correlated with persistent modifications of the epigen-
ome. The epigenetic information in human cells is stored
via mitotically heritable DNA methylation, organization
of the chromatin structure (for example, histone modifi-
cation), and regulatory RNAs. Together, these mechan-
isms are responsible for regulating gene expression
during cellular differentiation during embryonic develop-
ment and throughout life [1]. Our study focuses on the
DNA methylation patterns of the imprinted Insulin-Like
Growth Factor 2 (IGF2) gene, coding a well-characterized
growth factor active throughout embryogenesis and fetal
growth [2,3]. In normal human tissues only the paternal
IGF2 allele is transcribed; and its imprinting is regulated
by at least two differentially methylated regions (DMRs):
one is located upstream of the three IGF2 promoters that
are subject to imprinting (IGF2 DMR), and the other is
located upstream of the neighboring non-coding H19
gene (H19 DMR). The latter region is part of the imprint-
ing control region (ICR) which harbors binding sites for
the zinc finger protein CTCF. During early development,
imprint marks are erased in the primordial germ cells
and new methylation imprints are established according
to the germ cell. This has particularly been demonstrated
at the IGF2 DMR [4] and H19 DMR [4,5] in sperma-
togenic human cell stages. The progressive imprint
re-establishment of the DNA methylation imprint marks
throughout human spermatogenesis leads to fully methy-
lated IGF2 and H19 DMRs. Consequently, methylation is
only present on the paternally inherited allele in the off-
spring. Shifts in methylation established at these DMRs
can lead to loss of imprinting and transcription of IGF2
may be altered [6,7]. Hence, normal physiological
mechanisms or homeostasis in the body may be skewed
and lead to chronic diseases later in life. Until now, epi-
demiological studies have focused on maternal factors
and especially in utero exposures to certain nutritional or
environmental conditions as the potential explanation for
such disruptions or shifts in methylation at the DMRs
[8-10]. This can potentially contribute to a higher risk for
obesity [11], chronic diseases at later age [12], including
diabetes or cardiovascular diseases [13-15], or even can-
cer [16,17]. Animal experiments show that modification
of maternal diet during development can influence meta-
bolism in adulthood [18]. Although the underlying
mechanism and crucial time points of exposure are not
clear, changes in epigenetic regulation are now regarded
as a highly plausible explanation for linking the associa-
tions between dietary exposures in early life to the onset
of chronic diseases during adulthood. Several lines of evi-
dence suggest that pre- or periconceptional obesity of the
mother may affect metabolic programming [19-21].
Although paternal obesity is equally prevalent, the major-
ity of the epidemiological studies to date suggest in utero
exposures as the only possible origin of potential epige-
nomic modifications at birth. Obesity is associated with
over-nutrition, unbalanced food intake (such as low vege-
table consumption), and a sedentary lifestyle [22]. Conse-
quently, elucidating the epigenetic risks associated with
the current “Western” lifestyle on the next generations is
crucial. In the current report we determined whether
preconceptional obesity, in the mother or the father, is
associated with methylation patterns at the IGF2 DMRs
in newborns using DNA from leukocytes isolated from
umbilical cord blood at birth. By including paternal obe-
sity in our study we were able to examine a potential pre-
conceptional impact of the environment on imprint mark
reprogramming during male gametogenesis. Conse-
quently, we found that paternal obesity is associated with
a decrease in DNA methylation at the IGF2 DMR.
Methods
Study participants
We studied a subgroup of the first 98 families enrolled
in the Newborn Epigenetics Study cohort. Seventy-eight
mothers provided detailed information about the biolo-
gical fathers. One mother gave birth to twins, bringing
the total number of newborns with corresponding pater-
nal data to 79. The enrollment process was assisted by a
trained interviewer. Detailed recruitment strategies for
NEST have been described in a previous study [23].
English speaking pregnant mothers delivered between
July 2005 and November 2006 at Duke University Hos-
pital, Durham, NC.
Data collection
The questionnaire included maternal socio-demographic
data, such as age, marital status, race and education, as
well as multiple lifestyle or health characteristics (for
example, smoking, chronic diseases). One of the main
items of the survey included a detailed list of questions
about the mother’s and the father’s height, highest and
lowest weight ever, current and usual weight. Medical
records were used to verify medical conditions, and to
abstract gestation time, birth weight and the newborn’s
gender. Body mass index was calculated from the data
obtained from height and the mother’s weight before
pregnancy or the father’s current weight. Obesity was
defined as BMI ≥30 kg/m2.
Specimen collection
At delivery, umbilical cord blood samples were collected
in a vacuum blood collection tube coated with K3EDTA.
The tubes were centrifuged to isolate the buffy coat; this
leukocyte-containing buffy coat was then stored at
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-80ºC. Genomic DNA was extracted using Gentra Pure-
gene Reagents (Qiagen, Valencia, CA, USA).
DNA methylation analysis
IGF2 and H19 DMRs were analyzed by pyrosequencing.
The IGF2 DMR includes three CpG dinucleotides
upstream of IGF2 exon 3 (chr 11p15.5; CpG site 1:
2,169,518; CpG site 2: 2,169,515; and CpG site 3:
2,169,499; NCBI Human Genome Build 37/hg19). This
DMR has been previously evaluated by Cui et al. [6]
and Heijmans et al. [8]. The region studied for the H19
DMR encompasses four dinucleotides located upstream
of the H19 gene (chr 11p15.5; CpG site 1: 2,024,261,
CpG site 2: 2,024,259, CpG site 3: 2,024,257, and CpG
site 4: 2,024,254; NCBI Human Genome Build 37/hg19),
which is the first of six known sequence motifs that
bind the CTCF zinc finger protein [24,25]. The struc-
tural characteristics of these IGF2 and H19 loci and the
genomic coordinates of the assays have been presented
elsewhere [7,26]. Genomic DNA (800 ng) was treated
with sodium bisulfite [27], the IGF2/H19 regions were
amplified by PCR, and pyrosequencing was performed
in duplicate using a Pyromark Q96 MD pyrosequencing
instrument (Qiagen). Control assays were also run to
validate our methylation results. Detailed methodology,
including assay conditions and validation studies, have
been described previously [25].
Statistical methods
Variables were defined as follows: race (African American,
Caucasian, and other), age (as a continuous variable),
marital status (living with partner versus single), at least a
college graduate (yes or no), pre-pregnancy maternal and
paternal obesity (<30 versus ≥30 kg/m2), smoking status
(never/quit smoking when pregnant/continued smoking
during pregnancy), birth weight of the baby (<2.5 kg/
between 2.5 kg and 3.5 kg/≥3.5 kg), gestation time (<37
weeks versus ≥37 weeks), and gender of the baby (male or
female) (Table 1). Chi Square tests were used to compare
obesity of the mother and the father within different sub-
groups of pregnant women. If numbers were small (<5)
the Fisher exact test was used. We also compared the
characteristics for missing and non-missing experimental
methylation results and for missing and non-missing BMI
of the father. Methylation levels were distributed normally
in the groups studied (verified by using the Kolmogorov-
Smirnov test). Student’s t-tests were computed to test
for significant differences in the methylation means. We
assessed the effect of maternal and paternal obesity (BMI
≥30 kg/m2) on the methylation levels of the IGF2 and H19
DMRs, which were analyzed separately by individual CpG
site, as well as by the mean of the CpGs. To account for
batch effects from the laboratory tests on different days or
different plates we calculated the least square means (or
estimated marginal means) of each CpG site. We evalu-
ated potential confounding for paternal and maternal obe-
sity by means of multivariable regression analyses. We
used multiple regression analyses, separately for each
exposure and characteristics from Table 1. These multiple
regression analyses were used to predict DNA methylation
at each DMR site. To further explore whether the associa-
tion between obesity and DNA methylation varied by race,
we repeated these analyses in African Americans and Cau-
casians. Graphs representing the associations between
BMI and methylation outcomes were based on the pre-
dicted outcomes of the methylation means, after adjusting
for maternal age, smoking status, birth weight and gender.
Observations included in the regression analyses were
determined by the availability of laboratory measures for
the IGF2 and H19 DMRs. All statistical analyses were con-
ducted in SAS v9.2 (SAS Institute Inc., Cary, NC, USA),
and GraphPad Prism 5 was used to obtain Figures 1 and 2
(GraphPad Software Inc., La Jolla, CA, USA).
Ethics
The experimental research in this report was performed
with the approval of the Duke University Institutional
Review Board, reference number: Pro00014548; this
means that the research carried out is in compliance with
Table 1 Parental and newborn characteristics
NEST - Newborn Epigenetics Study Cohort 2005 to 2006 n %
BMI mother: BMI <30 (not obese) 59 67.8
BMI ≥30 (obese) 28 32.2
BMI father: BMI <30 (not obese) 63 79.7
BMI ≥30 (obese) 16 20.3
Marital status: Living with partner 72 74.2
Single 25 25.8
Education: Low (no college degree) 57 58.8
High (at least college degree) 40 41.2
Race: African American 38 38.8
Caucasian 56 57.1
Other or not specified 4 4.08
Maternal age: <30 years 56 57.1
≥30 years 42 42.9
Smoking: Mother never smoked 45 48.4
Quit smoking when pregnant 26 27.9
Smoked during pregnancy 22 23.7
Gestation time: Preterm (<37 weeks) 10 10.3
Normal (≥37 weeks) 87 86.7
Birth weight: <2.5 kg 16 16.5
≥2.5 kg 81 83.5
Baby gender: Male 48 49.5
Female 49 50.5
This sub-cohort includes all NEST families from whom babies were born at
Duke University Hospital between July 2005 and November 2006.
Characteristics of mothers, fathers and newborns are shown for the 98
participants when data were not missing.
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the Helsinki Declaration. All participants signed the
informed consent for the use of their medical record
data, questionnaire data, their newborn’s birth para-
meters and umbilical cord blood.
Results
Characteristics of study participants
The distributions of socio-demographic data are shown
in Table 1. Seventy-four percent of the mothers were liv-
ing with a partner, and nearly 26% were single. The
majority of the study population were Caucasians (57.1%)
or African Americans (38.8%), and the other races/ethni-
cities included Asians, Native Americans or non-specified
race (4.1%). A quarter of the mothers were between 25
and 29 years old (26.5%). Nearly 59% never obtained a
college degree, and were categorized as “low education”.
Approximately 24% of the mothers reported smoking
during pregnancy, and 32% were obese before pregnancy.
About 80% of the mothers provided data about the
father’s characteristics: 20% are obese. Approximately
16% of the newborns had a low birth weight, 10% was
born preterm and gender was equally distributed. None
of the included characteristics were associated with
paternal obesity, with the exception of obesity in the
mother (P = 0.01). For instance, potential associations
between birth weight and parental obesity were excluded
by Chi Square tests or Fisher exact tests; P-values were
0.7 for paternal and maternal obesity. Maternal obesity
was positively associated with single motherhood (P =
0.002), being African American (P <0.001) and being a
non-smoker (P = 0.06). Given that 19% of our subjects
did not report detailed information about the fathers, we
compared all measured characteristics and methylation
end-results in newborns with missing anthropometric
Figure 1 Methylation at the IGF2 and H19 DMRs in the offspring by parental obesity. The graphs represent the mean estimated
methylation values of 69 newborns at the IGF2 DMR, and 70 newborns at the H19 DMR. The IGF2 DMR results are based on 14 obese fathers
and 25 obese mothers; the results at the H19 DMR are based on 15 obese fathers and 23 obese mothers. For each exposure the differences of
the least square means of methylation percentages are shown at each CpG site (bold), as well as standard errors (SE) and P-values. Bars
represent standard errors.
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data about fathers versus those without missing data. The
majority of the missing paternal data (78%) were from
African American mothers with lower education. Single
mothers were less likely to answer questions about the
father’s weight and height (32.0%), compared with mar-
ried mothers or those living with a partner (13.9%), P =
0.07. Other characteristics and the methylation outcomes
did not differ significantly between both groups.
Associations between paternal or maternal obesity and
methylation profiles at the IGF2 and H19 DMRs in the
offspring
Using DNA extracted from umbilical cord blood leuko-
cytes we determined the levels of methylation at CpG sites
within the IGF2 and H19 DMRs in newborns. From the
79 samples in our cohort, we obtained experimental data
for 67 participants at the IGF2 DMR and for 70 partici-
pants at the H19 DMR. We further refer to these partici-
pants as our analytical cohort. No significant differences in
characteristics were found when comparing the missing
with the non-missing experimental methylation results for
both DMRs. We analyzed methylation outcomes by the
characteristics described in Table 1 and with the exception
of obesity (BMI ≥30 kg/m2), none showed significant asso-
ciations with methylation percentages at the IGF2 or H19
DMRs in our cohort. Figure 1 shows the estimated means
of methylation percentages by obesity of the parents.
Differences in methylation percentages among offspring
from obese fathers compared to non-obese fathers at
CpG1, CpG2, and CpG3 of the IGF2 DMR were: -3.36%
(P = 0.08), -3.56% (P = 0.01) and -3.57% (P = 0.02), respec-
tively; the mean methylation difference was: -3.50% (P =
0.02) (Figure 1). Methylation in offspring among obese
fathers was significantly lower than when compared to
fathers who were not obese. We observed no differences
in methylation percentages at the IGF2 DMR between off-
spring of obese and non-obese mothers. Differences in
methylation percentages at CpG1, CpG2 and CpG3 were
+2.09% (P = 0.18), +0.66% (P = 0.57) and +0.90% (P =
0.44), respectively; the mean methylation difference was
+1.19% (P = 0.32) (Figure 1).
At the H19 DMR we found no methylation differences
in the offspring of obese compared to non-obese fathers.
Differences in methylation percentages at CpG1, CpG2,
CpG3 and CpG4 of the H19 DMR were +1.95% (P =
0.37), +1.68% (P = 0.42), +1.75% (P = 0.38) and +1.49%
(P = 0.48), respectively; the mean methylation difference
was +1.74% (P = 0.40) (Figure 1). However, the methyla-
tion percentages at the CpG sites of the H19 DMR
among offspring from obese mothers were significantly
Figure 2 Offspring’s mean methylation % at the IGF2 DMR by BMI of the parents. The predicted methylation means at IGF2 DMR are
plotted by BMI of the father (upper graph), and BMI of the mother (lower graph); adjusted for maternal age, smoking status, BMI of the other
parent, the newborn’s birth weight and gender.
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higher at CpG1, CpG2, CpG3 and CpG4 compared to
offspring from non-obese mothers. The differences were
+3.56% (P = 0.04), +4.13% (P = 0.01), +4.08% (P = 0.01)
and +4.55% (P = 0.007), respectively; the mean methyla-
tion difference was +4.10% (P = 0.01) (Figure 1). In brief,
without adjusting for potential confounders we detected
significantly lower methylation at the IGF2 DMR asso-
ciated with paternal obesity, and significantly higher
methylation at the H19 DMR when the mother was
obese.
To assess the independent effects of preconceptional
maternal or paternal obesity on DNA methylation at the
IGF2 and H19 DMRs in newborns, we used multiple
regression models, controlling for potential confounders,
including maternal age, maternal smoking status, gender
of the baby, birth weight and experimental batch effects.
The results of the regression analyses, found in Table 2,
show that paternal obesity is inversely associated with
DNA methylation levels at the IGF2 DMR in newborns.
Controlling for potential confounding did not change
this relationship. After adjusting for several characteris-
tics, we observed a significant decrease in methylation
when fathers were obese, b-coefficient was -5.28 (P =
0.003) (Table 2, Model 3). Little difference for this asso-
ciation was observed when comparing the individual
CpG sites. The b-coefficients for CpG1, CpG2 and
CpG3 were -5.78 (P = 0.01), -5.18 (P = 0.002) and -4.76
(P = 0.007), respectively. In contrast, results for maternal
obesity indicated an increase in methylation at the IGF2
DMR, the b-coefficient was +3.08 (P = 0.05) when con-
trolling for the same characteristics (Table 2, Model 3).
The b-coefficients at the individual CpG-sites were
+4.23 (P = 0.04), +2.44 (P = 0.08), +2.42 (P = 0.12), for
CpG1, CpG2 and CpG3; with only CpG1 reaching sta-
tistical significance.
In our separate regression models by maternal and
paternal obesity, we observed a positive trend in DNA
methylation at the H19 DMR when adjusting for mater-
nal and newborn characteristics (Table 2, Models 1 and
2, respectively). The b-coefficient was +3.09 when the
fathers were obese, but this result was not significant
(P = 0.07), and +2.80 when the mothers were obese
(P = 0.05). The multivariate model with the mean
methylation percent as a dependent variable and several
measured maternal, paternal and newborn characteris-
tics as independent variables (Model 3) showed a b-
coefficient for offspring from obese fathers of +2.55 (P =
0.17), and a b-coefficient for offspring from obese
mothers of +1.05 (P = 0.54). Similar results were seen
when we evaluated the individual CpG sites (data not
shown).
We further stratified our analytical cohort by race
(Caucasian and African American) and repeated all
regression analyses described above. At the IGF2 DMR,
the outcome was similar as in our complete analytical
cohort. We calculated a b-coefficient of -5.16 in offspring
from obese fathers, among Caucasians (P = 0.01) (as in
Model 3); and a b-coefficient of -3.65 in offspring from
obese fathers, among African Americans. Although the
estimates suggest an inverse relationship in Caucasian
subjects, this effect was not significant among African
Americans (P = 0.34). These observations were based on
only 10 obese fathers in Caucasians, and only 4 obese
fathers in African Americans. At the H19 DMR, results
were also similar and in the same direction as those in
our complete analytical cohort. However, we found one
higher estimate in Model 1 for children from African
American obese fathers: b-coefficient was +8.14 (P =
0.007). But, this result was based on a small sample size
with only 6 obese African American fathers. Together
with our statistical power calculations we conclude that
the stratified analyses represent unstable estimates.
We further extended the regression analyses in our
analytical cohort by replacing the dichotomous obesity
variable by the continuous BMI variable. At the H19
DMR, we found a b-coefficient of +0.21 (P = 0.12) for
paternal BMI and +0.16 (P = 0.09) for maternal BMI,
controlling for the same variables as before; but these
results were still not significant. Whereas at the IGF2
DMR, our data reached a significant positive association
when both paternal and maternal BMI were used as inde-
pendent variables in the multivariate model; b-coeffi-
cients were -0.38 (P = 0.009), and +0.22 (P = 0.02),
respectively. These correlations between parental BMI
and the predicted mean methylation levels at the IGF2
DMR in the offspring are depicted in Figure 2.
Discussion
We explored the potential effect of parental obesity on
IGF2/H19 DMR methylation in newborns. We found a
significant decrease in methylation among newborns of
obese fathers at the IGF2 DMR in DNA extracted from
cord blood leucocytes. This finding remained significant
after controlling for potential confounders (b-coefficient =
-5.28, P = 0.003). Hypomethylation at the IGF2 DMR has
Table 2 Linear Regression Models: methylation at the
IGF2 and H19 DMRs in relation to parental obesity
Linear regression models IGF2 DMR H19 DMR
Obesity of: b SE P b SE P
Model 1 Father -3.83 1.48 0.01 +3.09 1.64 0.07
Model 2 Mother +2.38 1.30 0.08 +2.80 1.38 0.05
Model 3 Father
Mother
-5.28
+3.08
1.62
1.48
0.003
0.05
+2.55
+1.05
1.82
1.70
0.17
0.54
Obesity was defined as BMI ≥30 kg/m2. All models were adjusted for maternal
age and smoking status, as well as by the newborn’s birth weight and gender.
Models 1 and 2 include either maternal or paternal obesity. Model 3 includes
both maternal and paternal obesity.
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been associated with an increased risk of developing can-
cers, such as Wilms’ tumor [28], colorectal cancer [6] and
ovarian cancer [7]. We found no significant changes in
methylation levels associated with paternal obesity at the
H19 DMR region.
Obesity is a metabolic condition that has paradoxically
been associated with poverty, low quality of life, malnu-
trition and an imbalanced intake of nutrients [21,22].
Few epidemiological studies indicate potential correla-
tions between obesity or food supplies in the paternal
line and offspring’s birth weight [29], body-fat in prepu-
bertal girls [30], or mortality from chronic diseases
[31-33]. Epidemiological data regarding associations
between maternal obesity and the offspring’s birth weight
vary by study (reviewed by McDonald et al. [34]). We
examined possible associations between paternal or
maternal obesity and birth weight but detected no asso-
ciations. Epidemiological studies on maternal obesity-
related exposures generally show a positive association
between abnormally high BMI and congenital anomalies
(reviewed by Stothard et al. [35]). These harmful effects
are mostly attributed to in utero exposures to malnutri-
tion or overnutrition; while very often, data indicate the
importance of exposures at the very early stages of devel-
opment, even before conception. Research in animal
models suggests that potential diet-dependent transge-
nerational effects may be explained by changes in the
establishment of epigenetic gene regulatory marks
[12,36-38]. Analyses of adults born to mothers exposed
to poor nutrition during the Dutch famine indicated a 5%
decrease in methylation at the IGF2 DMR compared to
the same sex non-exposed siblings. Interestingly, the
magnitude of this effect is similar to the effect we observe
in offspring from obese fathers at the same locus. In the
Dutch famine cohort, exposure during the periconcep-
tional period was more important than during the second
or the third trimester of gestation [8]. Furthermore, not
only do exposures during early gestation cause harmful
health outcomes, but famine prior to conception has also
been associated with poor health [39]. Similar results
were found among Gambian children; they exhibit
altered DNA methylation at several metastable epialleles
according to the seasonal nutritional circumstances in
which they were conceived [40]. Both cohorts described
above did not directly examine the relationship with the
fathers’ dietary patterns; although they were most likely
exposed to the same famine or nutritional circumstances
as the mothers. Analysis of the Framingham Heart Study
indicates that early-onset paternal obesity, and not
maternal obesity, increases the odds of aberrant serum
levels of the metabolic biomarker ALT (alanine transami-
nase) in the offspring [41]. Studies on animal models
have shown similar associations. In rats, a high fat pater-
nal diet results in offspring with early onset of impaired
insulin secretion, altered expression of multiple genes
related to normal pancreatic beta-cell function, and
altered methylation at a putative regulatory region of the
Interleukin 13 receptor, alpha 2 gene [42]. Male mice
whose mothers were exposed to a high-fat diet were not
only obese, insulin insensitive and diabetic, they were
also capable of passing part of this phenotype to the next
generation, suggesting an underlying epigenetic mechan-
ism transmitted through germ cells [43]. To our knowl-
edge, our study is the first epidemiological study that
suggests a similar underlying epigenetic mechanism con-
ferred by harmful paternal dietary patterns or obesity.
Obesity is associated with elevated IGF2 circulating
levels [44] and increased estrogen levels [45]. Although we
did not include IGF2 protein levels in parents or offspring
in our current analyses, we earlier showed that hypo-
methylation at the IGF2 DMR is associated with higher
circulating IGF2 levels in the offspring [25,46]. This asso-
ciation was strongest in offspring from obese mothers,
independent of race. In brief, a decrease of 5% at the IGF2
DMR methylation corresponded to an increase of at least
10% in serum concentration of IGF2 [46]. In addition,
other studies have shown that small aberrant methylation
changes at the IGF2 or H19 DMR is linked to increased
expression of IGF2 [6,7,24,25,47], as well as an increased
susceptibility to chronic diseases [48-51]. Similar small
effects on DNA methylation have also been associated
with the use of assisted reproductive technologies [52], the
use of psychotropic drugs during pregnancy [53] and
smoking [25]. These subtle epigenetic changes have been
described as adaptive responses to the environment, while
major epigenetic shifts during development would cause
more detrimental consequences [25]. Furthermore, explor-
ing the CpG sites at the IGF2 and H19 DMRs may repre-
sent only a fraction of changes occurring elsewhere in the
genome. Environmental factors, among which is diet, have
been associated with changes in DNA methylation and
may have profound effects on genomic imprinting; accu-
mulation of these effects may result in disturbed metabolic
homeostasis [54]. Follow-up studies on the anthropo-
metric and other developmental factors of the NEST chil-
dren are underway to further examine the influence of
small changes in DNA methylations at several DMRs on
childhood obesity or other adverse consequences.
Evidence in animal studies indicates that DNA methyla-
tion at the IGF2/H19 locus in sperm might be under tight
control of estrogen [55], produced by adipocytes. This sug-
gests a mechanism by which increased exposure to estro-
gen could lead to inadequate establishment of methylation
at the IGF2 DMR in sperm. Alternatively, obesity-related
factors may also disrupt functioning of other components
of the epigenetic machinery leading to an inability to
appropriately establish imprint marks during spermato-
genesis, which is ongoing through adult male life [5].
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Offspring of obese fathers may, therefore, demonstrate
incomplete methylation. In order to further explore these
hypotheses, more research on the epigenetic effects of
obesity on human germ cells is needed.
Although our bivariate analysis did not indicate an
association between maternal obesity and DNA methyla-
tion at the IGF2 DMR in newborns, the regression analy-
sis showed that controlling for paternal obesity resulted
in an opposite effect, meaning that while paternal obesity
was associated with a decrease in methylation, maternal
obesity tended to be associated with an increase in
methylation, but this was only significant at one CpG
site. Using pre-pregnancy BMI instead of obesity in our
multivariate analysis strengthened this association. At the
H19 DMR, the bivariate analysis showed an increase of
4.1% when mothers were obese (P = 0.01). An increase in
DNA methylation by maternal pre-gestational BMI has
also been reported earlier in cord blood samples, more
particularly at the PPARG promoter [56]. Hypermethyla-
tion at the IGF2 or H19 DMR has been associated with
loss of imprinting of IGF2, and several disorders. For
instance, IGF2 imprinting defects have been implicated
in Silver-Russell syndrome [57], Wilms’ tumor [24,58],
hepatoblastoma [59] and ovarian cancer [7]. Our regres-
sion analyses at the H19 DMR showed that adjusting for
potential confounders, including paternal obesity or BMI,
diminished this positive association (Table 2, Model 3).
We attribute this to the fact that maternal and paternal
obesity are closely related and the fact that methylation
outcomes for both parental exposures are in the same
direction. A larger study is necessary to further explore
the potential impact of parental obesity on DNA methy-
lation at the H19 DMR. Furthermore, the exposure from
oocyte stage till birth to maternal obesity or related life-
styles is complex. Hormonal factors that may influence
DNA methylation cannot be ruled out. It has been shown
that the rat H19 DMR has an estrogen responsive ele-
ment, suggesting that estrogen can form a complex with
Dnmt1, a DNA methyl transferase, leading to DNA
methylation at a normally unmethylated maternal allele
[55].
A potential limitation of our study includes the use of
cord blood as a marker for the newborn’s epigenetic sta-
tus. However, we used isolated leucocytes and IGF2 is a
well studied imprinted gene whose germline DMRs
should be similarly methylated across all cell types, given
the establishment of the epigenetic profile prior to con-
ception. IGF2 and H19 DMR methylation profiles were
verified in DNA from different cell fractions from umbili-
cal cord blood and we found no differences across the
cell types [26]. Another possible limitation is proof of
paternity, and the reliability of the paternal anthropo-
metric data, which were reported by pregnant mothers.
However, the questions regarding the anthropometric
data were detailed and verified for consistency. We do
not expect that methylation outcomes are differential
with respect to the potential misclassification of expo-
sures. Nineteen percent of our population had missing
data about the father. The methylation outcomes of these
newborns were not included in our final analytical study
group. However, we compared methylation outcomes by
missing and non-missing characteristics of the fathers
and found no differences. We also compared all mea-
sured maternal and newborn characteristics in both
groups and most characteristics were similarly distribu-
ted. We found no significant differences when mothers
were single or not, but found significant differences by
education and race. Most missing data were among the
lower educated and African American mothers. As far as
we could test, education was not associated with obesity
in either of the parents, and race was only associated
with obesity of the mother. It is very likely we missed a
number of obese fathers from African Americans. We
cannot verify if paternal obesity is equally distributed in
all subgroups of missing and non-missing paternal data,
and, therefore, selection bias cannot be excluded. How-
ever, when reanalyzing our regression models with race
included as an independent variable, our results
remained the same; only the effect of maternal obesity
attenuated in Model 2 (Table 2) at H19 DMR, the b-coef-
ficient for maternal obesity became +2.18 (SE = 1.65, P =
0.19) (data not shown). Possibly, race is on the same cau-
sal pathway as obesity, regarding the effect on methyla-
tion outcomes. As mentioned in the results section, race
by itself was not associated with methylation outcomes at
neither of the two DMRs studied in this cohort. Never-
theless, given our earlier analyses on maternal exposures
showed a race dependent effect at the same imprinted
loci [53], we further stratified our data by race. The out-
comes were in the same direction as the complete analy-
tical cohort, but given the smaller numbers, the results
represented unstable estimates. In general, the small sam-
ple size remains a limitation in our study which may
partly explain why our results at the H19 DMR do not
reach statistical significance. Nevertheless, the data con-
cerning associations between IGF2 DMR methylation
and parental BMI or obesity reached sufficient power,
especially when studying offspring from fathers with high
BMI.
Conclusions
Our early findings suggest that lifestyle factors of par-
ents may be indirectly transmitted to the next genera-
tion via epigenetic mechanisms. We show that one of
the measurable lifestyle parameters, obesity of the father,
is associated with hypomethylation at the IGF2 DMR in
the offspring. Aberrant low methylation at this DMR
has been associated with adverse health outcomes. As a
Soubry et al. BMC Medicine 2013, 11:29
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consequence, our preliminary result may be important
for public health, especially in regard to the global bur-
den of obesity. We hypothesize that the molecular
mechanism behind our observation might be a hormo-
nal difference between obese and non-obese parents,
inducing an incomplete or unstable establishment of
methylation at the IGF2 DMR during gametogenesis. As
a result, exposures to adverse lifestyle factors or poor/
over-nutrition during spermatogenesis may affect the
reprogramming of methylation profiles at imprinted
genes. Further research is necessary to confirm this
hypothesis. Although our study population is small, this
is the first report in humans suggesting that paternal
obesity may disrupt the normal establishment of geno-
mic imprinting in germ cells.
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